Latest Stock Split Details
Key information about LENZ Therapeutics, Inc.'s most recent stock split
Split Date: 2024-03-22
Split Ratio: 1:7
Price Before Split: $2.31
Price After Split: $0.33
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 7.00 times fewer shares (a 1:7 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of LENZ Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2024-03-22 | 1:7 | Yes | $2.31 | $0.33 |
About LENZ Therapeutics, Inc.
Company overview and industry information
LENZ Therapeutics, Inc. (LENZ) operates in the Biotechnology industry. The recent 1-for-7 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to LENZ Therapeutics, Inc. Summary